 |
enfumafungin derivative B-(1,3)-D-glucan synthestis inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Invasive Candida infections, including candidemia |
| USA Market Approval | USA |
| USA Designation Date | 2016-05-10 00:00:00 |
| Sponsor | SCYNEXIS, Inc.;101 Hudson Street, Suite 3610;Jersey City, New Jersey, 07302 |
